Medicare Part D coverage · abiraterone acetate · RxCUI 2046585
abiraterone acetate 125 MG Oral Tablet [Yonsa]
Per the CMS 2026 Part D formulary file, abiraterone acetate 125 MG Oral Tablet [Yonsa] is covered by 1,900 Medicare Part D plans (37.6% of enrollable products), averaging Tier 4.2, with prior authorization required on 98.4% of covering formularies.
- 37.6%
- Plan coverage
- 1,900
- Plans covering
- T4.2
- Avg tier
- 98.4%
- Prior auth required
What the CMS Formulary Data Shows for abiraterone acetate 125 MG Oral Tablet [Yonsa]
Per the CMS 2026 Part D formulary file, abiraterone acetate 125 MG Oral Tablet [Yonsa] (RxNorm concept RXCUI 2046585, generic name abiraterone acetate) appears on 182 distinct formulary files spanning 1,900 Medicare Part D plan offerings - 37.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.2.
Real-world access to abiraterone acetate 125 MG Oral Tablet [Yonsa] depends on utilization management as much as tier placement: 98.4% of covering formularies require prior authorization. 0% require step therapy. 78% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 45,661 Part D beneficiaries filled abiraterone acetate 125 MG Oral Tablet [Yonsa] in 2023, with total plan-and-beneficiary spending of $876,989,041 and an average per-beneficiary annual cost of $19,206.52. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry abiraterone acetate 125 MG Oral Tablet [Yonsa] today.
Coverage Details
- Formularies covering
- 182
- Plans covering
- 1,900
- Coverage rate
- 37.6%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 98.4% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 78% of formularies
2023 Medicare Spending
- Beneficiaries
- 45,661
- Total spending
- $876,989,041
- Avg per beneficiary
- $19,206.52
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering abiraterone acetate 125 MG Oral Tablet [Yonsa]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Florida Complete Care-Duals VIP (HMO-POS D-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $0 | FL |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Elderplan Plus Long-Term Care (HMO-POS D-SNP) | Elderplan, Inc. | T1 | Yes | $0 | NY |
| Health Choice Pathway (HMO D-SNP) | Health Choice Arizona, Inc. | T1 | Yes | $0 | AZ |
| Healthfirst CompleteCare (HMO D-SNP) | Healthfirst Health Plan, Inc. | T1 | Yes | $0 | NY |
| IMCare Classic (HMO D-SNP) | Itasca Medical Care | T1 | Yes | $0 | MN |
| Johns Hopkins Advantage MD D-SNP (HMO D-SNP) | Hopkins Health Advantage, Inc. | T1 | Yes | $0 | MD |
| MetroPlus UltraCare (HMO D-SNP) | Metroplus Health Plan, Inc. | T1 | Yes | $0 | NY |
| Senior Whole Health SCO (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| Senior Whole Health SCO NHC (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| Molina One Care (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | Yes | $0 | MA |
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | Yes | $0 | CA |
| CCA One Care (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | Yes | $0 | MA |
| CCA Senior Care Options (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | Yes | $0 | MA |
| Elevate Medicare Choice (HMO D-SNP) | Denver Health Medical Plan, Inc. | T1 | Yes | $0 | CO |
Show the next 30 plans
| AllCare Advantage Redwood Rx (HMO D-SNP) | Allcare Health Plan, Inc. | T1 | Yes | $0 | OR |
| PrimeWest Senior Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | Yes | $0 | MN |
| Prime Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | Yes | $0 | MN |
| Alterwood Advantage Dual Secure (HMO D-SNP) | Alterwood Advantage, Inc. | T1 | Yes | $0 | MD |
| Nascentia Dual Advantage (HMO D-SNP) | Visiting Nurse Association OF Central NEW York | T1 | Yes | $0 | NY |
| Provider Partners Pennsylvania Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Pennsylvania, Inc | T1 | Yes | $0 | PA |
| Provider Partners North Carolina Community Plan (HMO I-SNP) | Provider Partners Health Plan OF North Carolina | T1 | Yes | $0 | NC |
| Provider Partners Indiana Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Indiana | T1 | Yes | $0 | IN |
| Provider Partners Missouri Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Missouri, Inc. | T1 | Yes | $0 | MO |
| Abilis Health Community (HMO I-SNP) | Signature Advantage, LLC | T1 | Yes | $0 | KY, TN |
| Arkansas Integrated Providers (AIP) Dual Advantage (HMO D-SNP) | Arkansas Superior Select, Inc. | T1 | Yes | $0 | AR |
| Community Care's Partnership Program (HMO D-SNP) | Community Care Health Plan, Inc. | T1 | No | $0 | WI |
| Platino Blindao (HMO D-SNP) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Enlace (HMO D-SNP) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Advance (HMO D-snp) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Plus (HMO D-snp) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $0 | PA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $0 | PA |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Health Options West Virginia Inc. | T1 | Yes | $0 | WV |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | Yes | $0 | DE |
| Tufts Health One Care (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | Yes | $0 | MA |
| Tufts Health One Care CW (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | Yes | $0 | MA |
| Tufts Health Plan Senior Care Options (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | Yes | $0 | MA |
| Tufts Health Plan Senior Care Options CW (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | Yes | $0 | MA |
| Florida Complete Care (HMO I-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $4.80 | FL |
| Florida Complete Care- In The Community (HMO-POS I-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $4.80 | FL |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Florida Inc | T1 | Yes | $4.80 | FL |
| Provider Partners Texas Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Texas, Inc. | T1 | Yes | $4.80 | TX |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is abiraterone acetate 125 MG Oral Tablet [Yonsa] covered by Medicare Part D?
Yes, abiraterone acetate 125 MG Oral Tablet [Yonsa] is covered by 1,900 Medicare Part D plans (37.6% of all Part D formularies).
What tier is abiraterone acetate 125 MG Oral Tablet [Yonsa] on Medicare Part D plans?
abiraterone acetate 125 MG Oral Tablet [Yonsa] averages Tier 4.2 across Part D plans, ranging from Tier 1 to Tier 5.
Does abiraterone acetate 125 MG Oral Tablet [Yonsa] require prior authorization?
98.4% of Part D formularies require prior authorization for abiraterone acetate 125 MG Oral Tablet [Yonsa]. Step therapy: 0%. Quantity limits: 78%.
How much does Medicare spend on abiraterone acetate 125 MG Oral Tablet [Yonsa]?
In 2023, total Medicare Part D spending on abiraterone acetate 125 MG Oral Tablet [Yonsa] was $876,989,041, covering 45,661 beneficiaries. The average spend per beneficiary was $19,206.52.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 24 HR selegiline 0.25 MG/HR Transdermal System [Emsam] T4.2
- lotilaner 2.5 MG/ML Ophthalmic Solution [Xdemvy] T4.2
- glutamine 5000 MG Powder for Oral Solution T4.2
- 1.7 ML denosumab-bbdz 70 MG/ML Injection [Wyost] T4.2
- {4 (apremilast 10 MG Oral Tablet [Otezla]) / 51 (apremilast 20 MG Oral Tablet [Otezla]) } Pack [Otezla 28-Day 10/20 Starter Pack] T4.2
- apremilast 20 MG Oral Tablet [Otezla] T4.2
Similar prior-authorization rate
- epoetin alfa-epbx 20000 UNT/ML Injectable Solution [Retacrit] 98.4% PA
- alanine 20.7 MG/ML / arginine 11.5 MG/ML / glycine 10.3 MG/ML / histidine 4.8 MG/ML / isoleucine 6 MG/ML / leucine 7.3 MG/ML / lysine 5.8 MG/ML / methionine 4 MG/ML / phenylalanine 5.6 MG/ML / proline 6.8 MG/ML / serine 5 MG/ML / threonine 4.2 MG/ML / tryptophan 1.8 MG/ML / tyrosine 0.4 MG/ML / valine 5.8 MG/ML Injectable Solution [Travasol 10] 98.4% PA
- 1.7 ML denosumab-bnht 70 MG/ML Injection [Bomyntra] 98.4% PA
- 1.7 ML denosumab-bnht 70 MG/ML Prefilled Syringe [Bomyntra] 98.4% PA
- risdiplam 5 MG Oral Tablet [Evrysdi] 98.4% PA
- arimoclomol 124 MG Oral Capsule [Miplyffa] 98.4% PA